WASHINGTON, D.C. - Plaintiffs in 20 federal lawsuits who claim that they were injured by contaminated compound drugs made by Franck's Lab Inc. on May 7 said they unanimously support centralization of cases in a multidistrict litigation but suggest transfer to federal court in Los Angeles rather than New Orleans, as suggested by the defendant (In Re: Franck's Pharmaceutical Products Liability Litigation, MDL Docket No. 2454, JPMDL; See 5/2/13, Page 28)....(read more)![]()
↧